FDA 503B outsourcing facilities in Minnesota
Minnesota has 1 FDA-registered 503B outsourcing facility in the PeptideGrids directory, 1 with FDA drug recalls on record, the earliest registered in 2026. 503B facilities compound sterile medications in bulk under FDA cGMP standards and are a primary supply route for compounded peptides and GLP-1s during drug shortages.
| Facility | City | FDA-registered since | FDA recalls |
|---|---|---|---|
| IntegraDose Compounding Services, LLC | Shoreview | 2026 | 7 |
503B compounding in Minnesota
A 503B outsourcing facility registers with the FDA under the Drug Quality and Security Act and is inspected against cGMP manufacturing standards. In addition to that federal registration, a facility shipping into or operating in Minnesota must hold the appropriate state pharmacy license. Verify any facility's current license with the Minnesota Board of Pharmacy.
Peptides and GLP-1s compounded in Minnesota
Facilities in Minnesota report compounding Oxytocin to the FDA. PeptideGrids grades the clinical evidence for each. Browse the full GLP-1 and therapeutic peptide databases.
Frequently asked questions
How many FDA 503B outsourcing facilities are in Minnesota?
1 FDA-registered 503B outsourcing facility is listed in Minnesota on PeptideGrids, the earliest registered in 2026.
Which Minnesota 503B facilities have FDA recalls on record?
1 of the 1 Minnesota facility has FDA drug recalls on record; the table above shows the count per facility.
How do I verify a pharmacy license in Minnesota?
Use the Minnesota Board of Pharmacy license lookup to confirm a facility's current license status.
Facilities sourced from the FDA registered outsourcing facilities list. Recall counts from the FDA openFDA drug enforcement database.